150 related articles for article (PubMed ID: 33348307)
1. Mechanistic insights into the intracellular release of doxorubicin from pH-sensitive liposomes.
Dos Reis SB; de Oliveira Silva J; Garcia-Fossa F; Leite EA; Malachias A; Pound-Lana G; Mosqueira VCF; Oliveira MC; de Barros ALB; de Jesus MB
Biomed Pharmacother; 2021 Feb; 134():110952. PubMed ID: 33348307
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.
Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
J Liposome Res; 2016 Dec; 26(4):276-87. PubMed ID: 26784587
[TBL] [Abstract][Full Text] [Related]
3. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy.
Paliwal SR; Paliwal R; Pal HC; Saxena AK; Sharma PR; Gupta PN; Agrawal GP; Vyas SP
Mol Pharm; 2012 Jan; 9(1):176-86. PubMed ID: 22091702
[TBL] [Abstract][Full Text] [Related]
4. Design and evaluation of pH-sensitive liposomes constructed by poly(2-ethyl-2-oxazoline)-cholesterol hemisuccinate for doxorubicin delivery.
Xu H; Hu M; Yu X; Li Y; Fu Y; Zhou X; Zhang D; Li J
Eur J Pharm Biopharm; 2015 Apr; 91():66-74. PubMed ID: 25660909
[TBL] [Abstract][Full Text] [Related]
5. Toxicological study of a new doxorubicin-loaded pH-sensitive liposome: A preclinical approach.
de Oliveira Silva J; Miranda SEM; Leite EA; de Paula Sabino A; Borges KBG; Cardoso VN; Cassali GD; Guimarães AG; Oliveira MC; de Barros ALB
Toxicol Appl Pharmacol; 2018 Aug; 352():162-169. PubMed ID: 29864484
[TBL] [Abstract][Full Text] [Related]
6. Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity.
Zhao Y; Ren W; Zhong T; Zhang S; Huang D; Guo Y; Yao X; Wang C; Zhang WQ; Zhang X; Zhang Q
J Control Release; 2016 Jan; 222():56-66. PubMed ID: 26682502
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-Loaded with C6 Ceramide and Doxorubicin: In Vitro Evaluation on HeLa, A2780-ADR, and H69-AR Cells.
Sriraman SK; Pan J; Sarisozen C; Luther E; Torchilin V
Mol Pharm; 2016 Feb; 13(2):428-37. PubMed ID: 26702994
[TBL] [Abstract][Full Text] [Related]
8. Liposomes co-encapsulating doxorubicin and glucoevatromonoside derivative induce synergic cytotoxic response against breast cancer cell lines.
Novais MVM; Gomes ER; Miranda MC; Silva JO; Gomes DA; Braga FC; Pádua RM; Oliveira MC
Biomed Pharmacother; 2021 Apr; 136():111123. PubMed ID: 33486211
[TBL] [Abstract][Full Text] [Related]
9. Liposomes-Camouflaged Redox-Responsive Nanogels to Resolve the Dilemma between Extracellular Stability and Intracellular Drug Release.
Ma J; Deng H; Zhao F; Deng L; Wang W; Dong A; Zhang J
Macromol Biosci; 2018 Jul; 18(7):e1800049. PubMed ID: 29732706
[TBL] [Abstract][Full Text] [Related]
10. Combination of doxorubicin with harmine-loaded liposomes exerting synergistic antitumor efficacy.
Lei J; Cong S; Song M; Zhang W; Peng G; Li X; Liu Y
Drug Dev Ind Pharm; 2018 Apr; 44(4):570-581. PubMed ID: 29260918
[TBL] [Abstract][Full Text] [Related]
11. pH-Sensitive, Long-Circulating Liposomes as an Alternative Tool to Deliver Doxorubicin into Tumors: a Feasibility Animal Study.
Silva JO; Fernandes RS; Lopes SC; Cardoso VN; Leite EA; Cassali GD; Marzola MC; Rubello D; Oliveira MC; de Barros AL
Mol Imaging Biol; 2016 Dec; 18(6):898-904. PubMed ID: 27172938
[TBL] [Abstract][Full Text] [Related]
12. Type of pH sensitive linker reveals different time-dependent intracellular localization, in vitro and in vivo efficiency in alpha-fetoprotein receptor targeted doxorubicin conjugate.
Mollaev M; Gorokhovets N; Nikolskaya E; Faustova M; Zabolotsky A; Zhunina O; Sokol M; Zamulaeva I; Severin E; Yabbarov N
Int J Pharm; 2019 Mar; 559():138-146. PubMed ID: 30599230
[TBL] [Abstract][Full Text] [Related]
13. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
Moosavian SA; Abnous K; Badiee A; Jaafari MR
Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819
[TBL] [Abstract][Full Text] [Related]
14. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models.
Chi Y; Yin X; Sun K; Feng S; Liu J; Chen D; Guo C; Wu Z
J Control Release; 2017 Sep; 261():113-125. PubMed ID: 28666726
[TBL] [Abstract][Full Text] [Related]
15. pH-sensitive charge-conversional and NIR responsive bubble-generating liposomal system for synergetic thermo-chemotherapy.
Chen MM; Song FF; Feng M; Liu Y; Liu YY; Tian J; Lv F; Zhang QQ
Colloids Surf B Biointerfaces; 2018 Jul; 167():104-114. PubMed ID: 29631221
[TBL] [Abstract][Full Text] [Related]
16. Folate-coated, long-circulating and pH-sensitive liposomes enhance doxorubicin antitumor effect in a breast cancer animal model.
de Oliveira Silva J; Fernandes RS; Ramos Oda CM; Ferreira TH; Machado Botelho AF; Martins Melo M; de Miranda MC; Assis Gomes D; Dantas Cassali G; Townsend DM; Rubello D; Oliveira MC; de Barros ALB
Biomed Pharmacother; 2019 Oct; 118():109323. PubMed ID: 31400669
[TBL] [Abstract][Full Text] [Related]
17. Brain tumor-targeted delivery and therapy by focused ultrasound introduced doxorubicin-loaded cationic liposomes.
Lin Q; Mao KL; Tian FR; Yang JJ; Chen PP; Xu J; Fan ZL; Zhao YP; Li WF; Zheng L; Zhao YZ; Lu CT
Cancer Chemother Pharmacol; 2016 Feb; 77(2):269-80. PubMed ID: 26666650
[TBL] [Abstract][Full Text] [Related]
18. Redox responsive liposomal nanohybrid cerasomes for intracellular drug delivery.
Zhou G; Li L; Xing J; Jalde S; Li Y; Cai J; Chen J; Liu P; Gu N; Ji M
Colloids Surf B Biointerfaces; 2016 Dec; 148():518-525. PubMed ID: 27690240
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary Codelivery of Doxorubicin and siRNA by pH-Sensitive Nanoparticles for Therapy of Metastatic Lung Cancer.
Xu C; Wang P; Zhang J; Tian H; Park K; Chen X
Small; 2015 Sep; 11(34):4321-33. PubMed ID: 26136261
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin loaded tumor-triggered targeting ammonium bicarbonate liposomes for tumor-specific drug delivery.
Cheng Y; Zou T; Dai M; He XY; Peng N; Wu K; Wang XQ; Liao CY; Liu Y
Colloids Surf B Biointerfaces; 2019 Jun; 178():263-268. PubMed ID: 30877911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]